These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 8235346)

  • 1. [Aluminum as an adjuvant in vaccines and post-vaccine reactions].
    Fiejka M; Aleksandrowicz J
    Rocz Panstw Zakl Hig; 1993; 44(1):73-80. PubMed ID: 8235346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life.
    Knuf M; Habermehl P; Faber J; Bock HL; Sänger R; Bogaerts H; Clemens R; Schuind A; du Prel JB; Schmitt HJ
    Vaccine; 2006 Jul; 24(27-28):5627-36. PubMed ID: 16740348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Itching nodules and hypersensitivity to aluminium after the use of adsorbed vaccines from SSI.
    Thierry-Carstensen B; Stellfeld M
    Vaccine; 2004 May; 22(15-16):1845. PubMed ID: 15121293
    [No Abstract]   [Full Text] [Related]  

  • 4. Persistent itching nodules after the fourth dose of diphtheria-tetanus toxoid vaccines without evidence of delayed hypersensitivity to aluminium.
    Netterlid E; Bruze M; Hindsén M; Isaksson M; Olin P
    Vaccine; 2004 Sep; 22(27-28):3698-706. PubMed ID: 15315849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for granulomas in children following immunization with aluminium-adsorbed vaccines: A Danish population-based cohort study.
    Hoffmann SS; Thiesson EM; Johansen JD; Hviid A
    Contact Dermatitis; 2022 Nov; 87(5):430-438. PubMed ID: 35778959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectroscopic characterization of antibodies adsorbed to aluminium adjuvants: correlation with antibody vaccine immunogenicity.
    Capelle MA; Brügger P; Arvinte T
    Vaccine; 2005 Feb; 23(14):1686-94. PubMed ID: 15705473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Aluminium adjuvant exposure through vaccines in France in 2018].
    Angrand L; Elnar AA; Authier FJ; Gherardi RK; Crépeaux G
    Ann Pharm Fr; 2020 Mar; 78(2):111-128. PubMed ID: 32081303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aluminium adjuvants--in retrospect and prospect.
    Lindblad EB
    Vaccine; 2004 Sep; 22(27-28):3658-68. PubMed ID: 15315845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraperitoneal administration of aluminium-based adjuvants produces severe transient systemic adverse events in mice.
    Freiberger SN; Leuthard DS; Duda A; Contassot E; Thallmair M; Kündig TM; Johansen P
    Eur J Pharm Sci; 2018 Mar; 115():362-368. PubMed ID: 29410031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aluminium-adjuvanted vaccines--a review of the current state of knowledge.
    Gołoś A; Lutyńska A
    Przegl Epidemiol; 2015; 69(4):731-4, 871-4. PubMed ID: 27139352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of the immune response to non-adsorbed antigens by aluminum-containing adjuvants.
    Romero Méndez IZ; Shi Y; HogenEsch H; Hem SL
    Vaccine; 2007 Jan; 25(5):825-33. PubMed ID: 17014935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aluminium hydroxide-induced granulomas in pigs.
    Valtulini S; Macchi C; Ballanti P; Cherel Y; Laval A; Theaker JM; Bak M; Ferretti E; Morvan H
    Vaccine; 2005 Jun; 23(30):3999-4004. PubMed ID: 15917121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in vaccine adjuvants.
    Singh M; O'Hagan D
    Nat Biotechnol; 1999 Nov; 17(11):1075-81. PubMed ID: 10545912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
    Vandepapelière P; Horsmans Y; Moris P; Van Mechelen M; Janssens M; Koutsoukos M; Van Belle P; Clement F; Hanon E; Wettendorff M; Garçon N; Leroux-Roels G
    Vaccine; 2008 Mar; 26(10):1375-86. PubMed ID: 18272264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (How) do aluminium adjuvants work?
    Brewer JM
    Immunol Lett; 2006 Jan; 102(1):10-5. PubMed ID: 16188325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of aluminium-containing adjuvants.
    White JL; Hem SL
    Dev Biol (Basel); 2000; 103():217-28. PubMed ID: 11214239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: impact of distinct additional adjuvants.
    Radosević K; Rodriguez A; Mintardjo R; Tax D; Bengtsson KL; Thompson C; Zambon M; Weverling GJ; Uytdehaag F; Goudsmit J
    Vaccine; 2008 Jul; 26(29-30):3640-6. PubMed ID: 18514980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenicity testing of plain and aluminium hydroxide-adsorbed whole-cell cholera vaccines.
    Joó I
    Acta Trop; 1979 Jun; 36(2):151-6. PubMed ID: 41423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro.
    Morefield GL; Sokolovska A; Jiang D; HogenEsch H; Robinson JP; Hem SL
    Vaccine; 2005 Feb; 23(13):1588-95. PubMed ID: 15694511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of aluminum adjuvant to experimental rabies vaccine].
    Lin H; Perrin P
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Jun; 13(2):133-5. PubMed ID: 12569779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.